Recent News

By Category: Research

Analysis: Bat Influenza Viruses and the Risk to Humans

GlobalBiodefense: Characterization of Uncultivable Bat Influenza Virus Using a Replicative Synthetic Virus. A study published on October 2nd in PLOS Pathogens addresses the question of whether or not bat flu exists based on detailed molecular and virological characterization. 

WHO | Experimental Ebola vaccines

WorldHealthOrganization- The WHO has announced that they have been assessing the status of work to test and eventually license two candidate Ebola vaccines. The two candidate vaccines have clinical-grade vials available for phase 1 pre-licensure clinical trials.

Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections

TheNewEnglandJournalofMedicine- Report by the W.H.O. on the  clinical and epidemiological characteristics of the Ebola epidemic in Guinea, Liberia, Nigeria, and Sierra Leone during the first 9 months of the epidemic (as of September, 14, Senegal had reported only a single case). The report furthermore documents trends in the epidemic thus far and projects expected case numbers  Read More »

Years of Preparation Pay Off with Ebola Diagnostic

Development of Self-Powered Chemical and Biological Sensors

GlobalBiodefense: New types of smart materials that can respond to selective stimuli hold promise in the development of novel platforms for self-powered chemical and biological (CB) sensors that can sense and destroy threat agents.